The Week Ahead: COS...
Health Care: Drugs
Jazz Pharmaceuticals PLC (JAZZ: NASDAQ)
$63.75 0.75 | 1.19%
05/24/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with JAZZ
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserMike
- UserHealth
- UserGFNN Stockdiagnostics 11
- Contributor10 Best-Performing Stocks i...
- UserS ACCT
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics
- User201201
Latest JAZZ Headlines from TheStreet
- Jazz Rises On Unusually High Volume (JAZZ) 04.17.13 | 04:04 pm
- Top Insider Trades: HLF FSYS JAZZ JMP 03.13.13 | 09:03 am
- Analysts' Actions: BTU JAZZ MYL SKUL TDG 03.11.13 | 08:03 am
- 3 Biotech Stocks Rising on Big Volume 02.27.13 | 02:02 pm
- Top Insider Trades: SHLD BWC NCT JAZZ 01.14.13 | 08:01 am
- Jazz Pharmaceuticals PLC (JAZZ): Today's Featured Drugs Winner 10.23.12 | 05:10 pm
- Insiders Trading JAZZ AMCX PCFG STK 10.05.12 | 08:10 am
- Jazz Reaches New 52-Week High (JAZZ) 10.02.12 | 10:10 am
- Jazz Stock Hits New 52-Week High (JAZZ) 09.18.12 | 10:09 am
- Healthy Retracements Refuel Bull Run
09.18.12 | 08:09 am
Press Releases for JAZZ
- Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders - PR Newswire 03.05.13 | 09:03 am
- Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders - PR Newswire 03.04.13 | 04:03 pm
- Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March - PR Newswire 02.27.13 | 09:02 am
- Http://www.jazzpharma.com/ - Business Wire 02.26.13 | 04:02 pm
- Jazz Pharmaceuticals To Report 2012 Fourth Quarter And Full Year Financial Results On February 26, 2013 - PR Newswire 02.11.13 | 04:02 pm
- Where Opportunity Is Found - Research Report On Jazz Pharmaceuticals Plc And Spectrum Pharmaceuticals, Inc. - PR Newswire 01.23.13 | 08:01 am
- Jazz Pharmaceuticals To Webcast Presentation At J.P. Morgan Healthcare Conference - PR Newswire 01.02.13 | 04:01 pm
- Jazz Pharmaceuticals Announces Presentation Of Largest Safety Trial To Date Of Patients Treated With Erwinaze® - PR Newswire 12.10.12 | 06:12 pm
- Jazz Pharmaceuticals Announces Issuance Of Additional Xyrem® Patent - PR Newswire 12.04.12 | 04:12 pm
- Jazz Pharmaceuticals Begins Clinical Trial Of Intravenously Administered Erwinaze® In Patients With Acute Lymphoblastic Leukemia - PR Newswire 12.03.12 | 04:12 pm
Partner Headlines for JAZZ
- Acorda: A Biotech Company To Consider - Seeking Alpha 04.13.13 | 09:04 am
- Stocks End Mixed As Volume Rises; Yandex, U.S. Silica Dive - Investor's Business Daily 03.12.13 | 04:03 pm
- Stocks Down Modestly In Afternoon; U.S. Silica Dives - Investor's Business Daily 03.12.13 | 01:03 pm
- Wall Street Mixed In Afternoon; Abaxis Hits New High - Investor's Business Daily 03.11.13 | 01:03 pm
- Jazz Pharmaceuticals: Playing A Sweet Song For Growth Investors - Seeking Alpha 03.11.13 | 09:03 am
- Stocks Hold Onto Morning Gains; OpenTable At New High - Investor's Business Daily 03.05.13 | 01:03 pm
- UPDATE: Citigroup Initiates Jazz Pharmaceuticals at Buy; Expecting Settlement to Remove Overhang - Benzinga 11.27.12 | 01:11 pm
- Stocks Improve Near Midday; Apple, Google Lift Nasdaq - Investor's Business Daily 11.09.12 | 12:11 pm
- Jazz Pharma 3Q Earnings In Line - Analyst Blog - Zacks 11.09.12 | 10:11 am
- Jazz Pharma Earnings Top Estimates As Xyrem Ramps - Investor's Business Daily 11.08.12 | 06:11 pm
